Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Post Market Drug Safety and Effectiveness

University of Alberta

$99,848.00

Using Genomics to Address Drug Safety in Children With Traumatic Injury: An Innovative Approach to a Common Problem.

FY 2009-10

Summary
In Canada, countless children have accidents and injuries every day. These injuries often cause pain that is tough for the child (and their family) to deal with. Children with injuries are commonly told to take painkillers at home for their pain. These painkillers are variable in how well they work. They can also cause pretty bad side effects, that may cause a family to stop using them, even though the child is still in pain. Under-treated pain can cause both immediate and long-term ill effects for a child. The effects of medicine (both good and bad) might be due, in part, to each person's DNA. DNA is the building block of our bodies, and is what make each person a little bit different from the next. Some people's DNA allows them to have more pain relief than others, even when two people are given the same medicine. These DNA differences can also cause one person to have more bad side effects with a medicine, than another person. This study will try to figure out how DNA changes can affect a child's ability to have lesser side effects and feel better with commonly used pain medicines. We will then use this information to help figure out the best medicines to prescribe for each unique child.
Program
Catalyst Grant: Post Market Drug Safety and Effectiveness
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
192717
Name
Ali Samina
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Projecttitle
Using Genomics to Address Drug Safety in Children With Traumatic Injury: An Innovative Approach to a Common Problem.
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$99,848
Cihrequipment2
$0
Programname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Keyworddelim
Child Health; Drug Effectiveness; Pain; Pharmacogenomics; Traumatic Injury
Abstract
In Canada, countless children have accidents and injuries every day. These injuries often cause pain that is tough for the child (and their family) to deal with. Children with injuries are commonly told to take painkillers at home for their pain. These painkillers are variable in how well they work. They can also cause pretty bad side effects, that may cause a family to stop using them, even though the child is still in pain. Under-treated pain can cause both immediate and long-term ill effects for a child. The effects of medicine (both good and bad) might be due, in part, to each person's DNA. DNA is the building block of our bodies, and is what make each person a little bit different from the next. Some people's DNA allows them to have more pain relief than others, even when two people are given the same medicine. These DNA differences can also cause one person to have more bad side effects with a medicine, than another person. This study will try to figure out how DNA changes can affect a child's ability to have lesser side effects and feel better with commonly used pain medicines. We will then use this information to help figure out the best medicines to prescribe for each unique child.
Competitiondate
200910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ali, Samina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $99,848~ $0~
University of Alberta - $99,848 Grant (2009-10) | Canada Spends